Skip to main content

4 Result(s)

within DK Hossfeld Remove this filter

and

  1. No Access

    Article

    The novel t(11;12;18)(q21;q13;q21) represents a variant translocation of the t(11;18)(q21;q21) associated with MALT-type lymphoma

    J Dierlamm, EM Murga Penas, M Daibata, H Tagushi, K Hinz, M Baens, J Cools… in Leukemia (2002)

  2. No Access

    Article

    Combination of aclarubicin and etoposide for the treatment of advanced acute myeloid leukemia: results of a prospective multicenter phase II trial

    In order to develop new strategies for the treatment of relapsed or refractory acute myeloid leukemia, the German AML Cooperative Group performed a prospective multicenter phase II study to evaluate the antile...

    W Kern, J Braess, A Grote-Metke, H Kuse, R Fuchs, DK Hossfeld, A Reichle… in Leukemia (1998)

  3. No Access

    Article

    Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia

    FLT4 represents a recently cloned member of class III receptor tyrosine kinases which include receptors for the angiogenic growth factor VEGF, namely FLT1 and KDR. The ligand of FLT4 has been identified as VEG...

    W Fielder, U Graeven, S Ergün, S Verago, N Kilic, M Stockschläder, DK Hossfeld in Leukemia (1997)

  4. No Access

    Article

    P-glycoprotein expression in normal and reactive bone marrows

    The expression of mdr1 gene product P-glycoprotein (P-gp) was investigated in 53 normal and reactive bone marrows by means of immunocytochemistry, using the monoclonal antibody (mAb) C219 and the alkaline phos...

    S Hegewisch-Becker, M Fliegner, T Tsuruo, A Zander, W Zeller… in British Journal of Cancer (1993)